We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $228M
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
10 Year Est. Return
AUM
$156M
AUM Growth
+$7.88M
Cap. Flow
+$3.67M
Cap. Flow %
2.36%
Top 10 Hldgs %
37.36%
Holding
198
New
22
Increased
77
Reduced
70
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 11.17%
2 Healthcare 8.3%
3 Consumer Discretionary 7.72%
4 Financials 5.49%
5 Energy 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUN icon
151
Cedar Fair
FUN
$1.89B
$239K 0.15%
+7,846
New +$263K
KOF icon
152
Coca-Cola Femsa
KOF
$22.5B
$236K 0.15%
+2,443
New +$232K
FISV
153
Fiserv Inc
FISV
$29.7B
$234K 0.15%
+1,356
New +$246K
PLTR icon
154
Palantir
PLTR
$295B
$232K 0.15%
+1,705
New +$200K
FTGC icon
155
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.97B
$229K 0.15%
9,284
-4,585
-33% -$113K
FIS icon
156
Fidelity National Information Services
FIS
$24.2B
$225K 0.14%
2,764
-962
-26% -$74.8K
CSGP icon
157
CoStar Group
CSGP
$12.2B
$225K 0.14%
2,797
+263
+10% +$20.5K
PFE icon
158
Pfizer
PFE
$143B
$225K 0.14%
9,277
+38
+0.4% +$886
NLR icon
159
VanEck Uranium + Nuclear Energy ETF
NLR
$3.68B
$223K 0.14%
2,003
-1,084
-35% -$96.4K
NICE icon
160
Nice
NICE
$6.15B
$219K 0.14%
1,297
-347
-21% -$55.9K
DJAN icon
161
FT Vest US Equity Deep Buffer ETF January
DJAN
$470M
$218K 0.14%
5,416
BALL icon
162
Ball Corp
BALL
$17.5B
$218K 0.14%
+3,891
New +$203K
CL icon
163
Colgate-Palmolive
CL
$75B
$218K 0.14%
2,399
+222
+10% +$20.3K
DE icon
164
Deere & Co
DE
$165B
$214K 0.14%
421
-34
-7% -$16.6K
CACI icon
165
CACI
CACI
$10.8B
$213K 0.14%
+447
New +$198K
IQV icon
166
IQVIA
IQV
$40.7B
$212K 0.14%
+1,343
New +$202K
IREN icon
167
Iris Energy
IREN
$10.5B
$197K 0.13%
+13,530
New +$110K
NVTS icon
168
Navitas Semiconductor
NVTS
$2.54B
$160K 0.1%
24,368
-828
-3% -$3.19K
BBDC icon
169
Barings BDC
BBDC
$869M
$111K 0.07%
12,125
-5,299
-30% -$47.1K
MDXH icon
170
MDxHealth
MDXH
$20.7M
$72K 0.05%
32,594
-1,182
-3% -$2.22K
BLND icon
171
Blend Labs
BLND
$436M
$60.5K 0.04%
18,347
-662
-3% -$2.24K
CRDF icon
172
Cardiff Oncology
CRDF
$63M
$44.1K 0.03%
13,995
-470
-3% -$1.43K
EMTL
173
DELISTED
State Street DoubleLine Emerging Markets Fixed Income ETF
EMTL
-5,570
Closed -$240K
GHYG icon
174
iShares US & Intl High Yield Corp Bond ETF
GHYG
$194M
-5,355
Closed -$239K
GLDM icon
175
SPDR Gold MiniShares Trust
GLDM
$27.5B
-24,289
Closed -$1.5M

Similar funds

Castleview Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Castleview Partners held 198 positions worth $156M, up 5.3% from $148M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Castleview Partners's Q2 2025 filing shows 22 new, 77 increased, 70 reduced and 26 closed positions. Its largest new stake was Regan Fixed Rate MBS ETF: 228,539 shares worth $5.86M. The largest sale was ProShares UltraPro QQQ, an estimated $1.59M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 8.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Castleview Partners's largest Q2 2025 buy was Regan Fixed Rate MBS ETF: 228,539 shares worth $5.86M.
  • Castleview Partners added most to Apple in Q2 2025, an estimated $2.73M increase.
  • Castleview Partners's biggest Q2 2025 reduction was ProShares UltraPro QQQ, cutting an estimated $1.59M.
  • Castleview Partners fully exited SPDR Gold MiniShares Trust in Q2 2025, selling an estimated $1.5M.
  • Castleview Partners's ten largest holdings make up 37% of its $156M portfolio in Q2 2025.
  • Castleview Partners opened 22 new positions and closed 26 in Q2 2025.
  • Castleview Partners's portfolio value rose 5.3% quarter-over-quarter to $156M.

Based on Castleview Partners's 13F filing for Q2 2025, filed 16 Jul 2025.